Kim Hye Sun, Kim Tae Jin, Lee In Ho, Hong Sung Ran
Department of Pathology, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea.
Department of Obstetrics and Gynecology, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea.
J Gynecol Oncol. 2016 Sep;27(5):e49. doi: 10.3802/jgo.2016.27.e49. Epub 2016 May 16.
This study aimed to examine the meaning and usefulness of sexually transmitted infection (STI) test when caring for patients who have abnormal cervical cytology and/or positive high-risk human papillomavirus (HPV) DNA test results.
Among patients who underwent liquid-based cervical cytology and HPV DNA tests at the Obstetrics and Gynecology outpatient clinic, 800 patients who showed abnormal cervical cytology were compared with 200 patients in the control group. Both groups were simultaneously tested via multiplex real-time polymerase chain reaction for seven types of STI-causative microorganisms.
The positive rate of high-risk HPV infection in total STIs positive group was 1.47 times higher than that of total STIs negative group. The probability of a cytological diagnosis of a grade equal to or higher than atypical squamous cells-cannot exclude high grade squamous intraepithelial lesion (ASC-H) was significantly higher in patients testing positive for total STIs (1.46 times), Chlamydia trachomatis (3.21 times), or Mycoplasma genitalicum (3.58 times) than in those testing negative. The total STIs positive rate was significantly higher for those having a cytological diagnosis of a grade equal to or higher than atypical squamous cells of undetermined significance (ASC-US) when high-risk HPV test result was negative.
Correlations were present not only between STIs and high-risk HPV infection but also between abnormal cervical cytology and STIs. Therefore, additional evaluation of STIs will be helpful to appropriately diagnose and treat patients with abnormal cervical cytology, positive results on high-risk HPV DNA test, or a cytological diagnosis of ASC-US despite negative high-risk HPV DNA test result.
本研究旨在探讨在护理宫颈细胞学异常和/或高危型人乳头瘤病毒(HPV)DNA检测结果呈阳性的患者时,性传播感染(STI)检测的意义和实用性。
在妇产科门诊接受液基宫颈细胞学和HPV DNA检测的患者中,将800例宫颈细胞学异常的患者与200例对照组患者进行比较。两组同时通过多重实时聚合酶链反应检测7种性传播感染致病微生物。
性传播感染总体阳性组的高危型HPV感染阳性率比性传播感染总体阴性组高1.47倍。性传播感染总体、沙眼衣原体或生殖支原体检测呈阳性的患者,其细胞学诊断为非典型鳞状细胞-不能排除高级别鳞状上皮内病变(ASC-H)及以上级别的概率,显著高于检测呈阴性的患者(分别为1.46倍、3.21倍和3.58倍)。高危型HPV检测结果为阴性时,细胞学诊断为意义不明确的非典型鳞状细胞(ASC-US)及以上级别的患者,其性传播感染总体阳性率显著更高。
性传播感染与高危型HPV感染之间、宫颈细胞学异常与性传播感染之间均存在相关性。因此,对性传播感染进行额外评估,将有助于对宫颈细胞学异常、高危型HPV DNA检测结果呈阳性或高危型HPV DNA检测结果为阴性但细胞学诊断为ASC-US的患者进行恰当的诊断和治疗。